Literature DB >> 30704900

BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.

Dali Zong1, Salomé Adam2, Yifan Wang3, Hiroyuki Sasanuma4, Elsa Callén1, Matilde Murga5, Amanda Day1, Michael J Kruhlak6, Nancy Wong1, Meagan Munro2, Arnab Ray Chaudhuri7, Baktiar Karim8, Bing Xia9, Shunichi Takeda4, Neil Johnson3, Daniel Durocher10, André Nussenzweig11.   

Abstract

BRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1+/-RNF168-/- cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRCA1; PALB2; RAD51; RNF168; cancer; chromatin ubiquitylation; genome stability; haploinsufficiency; homologous recombination; replication fork protection; resection

Mesh:

Substances:

Year:  2019        PMID: 30704900      PMCID: PMC6430682          DOI: 10.1016/j.molcel.2018.12.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  75 in total

1.  53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination.

Authors:  John P Manis; Julio C Morales; Zhenfang Xia; Jeffery L Kutok; Frederick W Alt; Phillip B Carpenter
Journal:  Nat Immunol       Date:  2004-04-11       Impact factor: 25.606

2.  RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins.

Authors:  Carsten Doil; Niels Mailand; Simon Bekker-Jensen; Patrice Menard; Dorthe Helena Larsen; Rainer Pepperkok; Jan Ellenberg; Stephanie Panier; Daniel Durocher; Jiri Bartek; Jiri Lukas; Claudia Lukas
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

3.  Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice.

Authors:  Pia Rantakari; Jenni Nikkilä; Heli Jokela; Roxana Ola; Katri Pylkäs; Heidi Lagerbohm; Kirsi Sainio; Matti Poutanen; Robert Winqvist
Journal:  Hum Mol Genet       Date:  2010-05-18       Impact factor: 6.150

4.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

5.  Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair.

Authors:  Anyong Xie; Andrea Hartlerode; Manuel Stucki; Shobu Odate; Nadine Puget; Amy Kwok; Ganesh Nagaraju; Catherine Yan; Frederick W Alt; Junjie Chen; Stephen P Jackson; Ralph Scully
Journal:  Mol Cell       Date:  2007-12-28       Impact factor: 17.970

6.  BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

Authors:  Rinske Drost; Kiranjit K Dhillon; Hanneke van der Gulden; Ingrid van der Heijden; Inger Brandsma; Cristina Cruz; Dafni Chondronasiou; Marta Castroviejo-Bermejo; Ute Boon; Eva Schut; Eline van der Burg; Ellen Wientjens; Mark Pieterse; Christiaan Klijn; Sjoerd Klarenbeek; Fabricio Loayza-Puch; Ran Elkon; Liesbeth van Deemter; Sven Rottenberg; Marieke van de Ven; Dick H W Dekkers; Jeroen A A Demmers; Dik C van Gent; Reuven Agami; Judith Balmaña; Violeta Serra; Toshiyasu Taniguchi; Peter Bouwman; Jos Jonkers
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

7.  The Histone Chaperones ASF1 and CAF-1 Promote MMS22L-TONSL-Mediated Rad51 Loading onto ssDNA during Homologous Recombination in Human Cells.

Authors:  Ting-Hsiang Huang; Faith Fowler; Chin-Chuan Chen; Zih-Jie Shen; Barry Sleckman; Jessica K Tyler
Journal:  Mol Cell       Date:  2018-02-22       Impact factor: 17.970

8.  BRCA1 haploinsufficiency for replication stress suppression in primary cells.

Authors:  Shailja Pathania; Sangeeta Bade; Morwenna Le Guillou; Karly Burke; Rachel Reed; Christian Bowman-Colin; Ying Su; David T Ting; Kornelia Polyak; Andrea L Richardson; Jean Feunteun; Judy E Garber; David M Livingston
Journal:  Nat Commun       Date:  2014-11-17       Impact factor: 14.919

9.  The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

Authors:  Yifan Wang; Andrea J Bernhardy; Cristina Cruz; John J Krais; Joseph Nacson; Emmanuelle Nicolas; Suraj Peri; Hanneke van der Gulden; Ingrid van der Heijden; Shane W O'Brien; Yong Zhang; Maribel I Harrell; Shawn F Johnson; Francisco J Candido Dos Reis; Paul D P Pharoah; Beth Karlan; Charlie Gourley; Diether Lambrechts; Georgia Chenevix-Trench; Håkan Olsson; Javier J Benitez; Mark H Greene; Martin Gore; Robert Nussbaum; Siegal Sadetzki; Simon A Gayther; Susanne K Kjaer; Alan D D'Andrea; Geoffrey I Shapiro; David L Wiest; Denise C Connolly; Mary B Daly; Elizabeth M Swisher; Peter Bouwman; Jos Jonkers; Judith Balmaña; Violeta Serra; Neil Johnson
Journal:  Cancer Res       Date:  2016-05-01       Impact factor: 12.701

10.  The shieldin complex mediates 53BP1-dependent DNA repair.

Authors:  Sylvie M Noordermeer; Salomé Adam; Dheva Setiaputra; Marco Barazas; Stephen J Pettitt; Alexanda K Ling; Michele Olivieri; Alejandro Álvarez-Quilón; Nathalie Moatti; Michal Zimmermann; Stefano Annunziato; Dragomir B Krastev; Feifei Song; Inger Brandsma; Jessica Frankum; Rachel Brough; Alana Sherker; Sébastien Landry; Rachel K Szilard; Meagan M Munro; Andrea McEwan; Théo Goullet de Rugy; Zhen-Yuan Lin; Traver Hart; Jason Moffat; Anne-Claude Gingras; Alberto Martin; Haico van Attikum; Jos Jonkers; Christopher J Lord; Sven Rottenberg; Daniel Durocher
Journal:  Nature       Date:  2018-07-18       Impact factor: 49.962

View more
  40 in total

1.  RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.

Authors:  Parasvi S Patel; Karan Joshua Abraham; Kiran Kumar Naidu Guturi; Marie-Jo Halaby; Zahra Khan; Luis Palomero; Brandon Ho; Shili Duan; Jonathan St-Germain; Arash Algouneh; Francesca Mateo; Samah El Ghamrasni; Haithem Barbour; Daniel R Barnes; Jonathan Beesley; Otto Sanchez; Hal K Berman; Grant W Brown; El Bachir Affar; Georgia Chenevix-Trench; Antonis C Antoniou; Cheryl H Arrowsmith; Brian Raught; Miquel Angel Pujana; Karim Mekhail; Anne Hakem; Razqallah Hakem
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

2.  Critical roles of Rad54 in tolerance to apigenin-induced Top1-mediated DNA damage.

Authors:  Zilu Zhao; Xiaohua Wu; Fang He; Cuifang Xiang; Xiaoyu Feng; Xin Bai; Xin Liu; Jingxia Zhao; Shunichi Takeda; Yong Qing
Journal:  Exp Ther Med       Date:  2021-03-18       Impact factor: 2.447

Review 3.  BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis.

Authors:  John J Krais; Neil Johnson
Journal:  Cancer Res       Date:  2020-08-03       Impact factor: 12.701

4.  Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.

Authors:  Justine Sitz; Sophie Anne Blanchet; Steven F Gameiro; Elise Biquand; Tia M Morgan; Maxime Galloy; Julien Dessapt; Elise G Lavoie; Andréanne Blondeau; Brandon C Smith; Joe S Mymryk; Cary A Moody; Amélie Fradet-Turcotte
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

5.  53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy.

Authors:  Iris Eke; Dali Zong; Molykutty J Aryankalayil; Veit Sandfort; Michelle A Bylicky; Barbara H Rath; Edward E Graves; André Nussenzweig; C Norman Coleman
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

6.  53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.

Authors:  Elsa Callen; Dali Zong; Wei Wu; Nancy Wong; Andre Stanlie; Momoko Ishikawa; Raphael Pavani; Lavinia C Dumitrache; Andrea K Byrum; Carlos Mendez-Dorantes; Paula Martinez; Andres Canela; Yaakov Maman; Amanda Day; Michael J Kruhlak; Maria A Blasco; Jeremy M Stark; Nima Mosammaparast; Peter J McKinnon; André Nussenzweig
Journal:  Mol Cell       Date:  2019-10-22       Impact factor: 17.970

7.  RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of BRCA1-Null Cancers.

Authors:  John J Krais; Yifan Wang; Andrea J Bernhardy; Emma Clausen; Jessica A Miller; Kathy Q Cai; Clare L Scott; Neil Johnson
Journal:  Cancer Res       Date:  2020-03-25       Impact factor: 12.701

Review 8.  The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.

Authors:  Madalena Tarsounas; Patrick Sung
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-24       Impact factor: 94.444

9.  BRCA1 Mutational Complementation Induces Synthetic Viability.

Authors:  Joseph Nacson; Daniela Di Marcantonio; Yifan Wang; Andrea J Bernhardy; Emma Clausen; Xiang Hua; Kathy Q Cai; Esteban Martinez; Wanjuan Feng; Elsa Callén; Wei Wu; Gaorav P Gupta; Joseph R Testa; André Nussenzweig; Stephen M Sykes; Neil Johnson
Journal:  Mol Cell       Date:  2020-04-30       Impact factor: 17.970

Review 10.  Understanding and overcoming resistance to PARP inhibitors in cancer therapy.

Authors:  Mariana Paes Dias; Sarah C Moser; Shridar Ganesan; Jos Jonkers
Journal:  Nat Rev Clin Oncol       Date:  2021-07-20       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.